Learn about the OASIS-4 trial results, benefits, and what comes next
Some patients may benefit from specific probiotic strains to help prevent antibiotic-associated diarrhea, though evidence varies by strain and indicationdiscuss this option with your healthcare provider
Thanks, Nicholas and Sam
However, despite these advantages, the clinical use of native GLP-1 is significantly limited by its short plasma half-life (12 min), owing to rapid enzymatic degradation by DPP-4 and renal clearance
Furthermore, a pragmatic, randomized, controlled clinical study was conducted with 230 PCOS women, randomly assigned to the NAC group (1.8 g/day oral NAC, n = 115) or the control group ( n = 115)
The reality is that every time I see a patient for overweight or obese treatment, and they are interested in starting a medication to treat this disease, I tell them that we do this with the understanding that the use of the medication will likely be long-term, or maybe for the rest of their lives. Blaha said he is of the opinion that more creative approaches to using GLP-1 agents are coming that may apply to cardiologists looking to put patients on an injectable weight-loss strategy to reduce their CV risk, but more as a helpful boost than a lifelong commitment